Clinical Trial Update: Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating KN057 as prophylaxis for Hemophilia A or Hemophilia B without inhibitors is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KN057

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Hemophilia A Without Inhibitor, Hemophilia B Without Inhibitor | Phase 3 | Status: ACTIVE_NOT_RECRUITING